TrialClinical rheumatology1998

A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids.

R Olin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.